Clinical Trial Update: Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the addition of XS15 multi-peptide vaccination to standard postoperative radiotherapy and temozolomide in newly diagnosed glioblastoma;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)
• XS15 peptide vaccine (XS15 peptide vaccine)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Glioblastoma Multiforme of Brain | Phase 1 | Status: COMPLETED